Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals, Inc. (REGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 872589.
Total stock buying since 2005: $2,475,753,844.
Total stock sales since 2005: $14,586,084,237.
Total stock option exercises since 2005: $1,313,104,322.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 0 | $0 | 210,364 | $207,522,474 | 616,322 | $254,112,622 |
2023 | 0 | $0 | 95,808 | $78,349,729 | 273,334 | $75,352,970 |
2022 | 0 | $0 | 209,705 | $142,182,035 | 469,330 | $145,352,340 |
2021 | 0 | $0 | 563,365 | $351,623,746 | 2,003,096 | $333,732,044 |
2020 | 0 | $0 | 24,311,062 | $12,445,396,750 | 1,955,372 | $164,839,706 |
2019 | 0 | $0 | 416,206 | $143,310,975 | 917,671 | $23,311,139 |
2018 | 0 | $0 | 427,003 | $148,810,340 | 927,576 | $18,552,974 |
2017 | 462,141 | $212,021,764 | 137,384 | $65,407,790 | 900,886 | $27,301,249 |
2016 | 148,669 | $62,482,433 | 20,663 | $8,394,544 | 774,368 | $17,691,794 |
2015 | 260,466 | $131,463,987 | 420,930 | $219,457,542 | 678,280 | $37,168,578 |
2014 | 6,498,829 | $2,040,580,495 | 592,551 | $211,494,397 | 1,689,378 | $74,072,416 |
2013 | 0 | $0 | 979,452 | $254,768,275 | 1,464,593 | $33,265,521 |
2012 | 0 | $0 | 1,215,019 | $159,380,088 | 2,319,093 | $46,475,631 |
2011 | 0 | $0 | 729,476 | $37,856,945 | 1,678,597 | $36,895,258 |
2010 | 1,034,901 | $28,971,078 | 317,918 | $9,118,977 | 332,278 | $5,014,862 |
2009 | 12,500 | $234,087 | 114,271 | $2,249,950 | 651,002 | $5,760,483 |
2008 | 0 | $0 | 156,479 | $3,272,738 | 500,195 | $4,022,051 |
2007 | 0 | $0 | 224,867 | $5,157,435 | 316,441 | $3,033,949 |
2006 | 0 | $0 | 443,650 | $8,648,660 | 580,125 | $5,427,485 |
2005 | 0 | $0 | 7,562,667 | $83,680,847 | 135,000 | $1,721,250 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-11 | 0 | $0 | 1,000 | $844,610 | 1,000 | $381,400 |
2024-10 | 0 | $0 | 1,100 | $1,159,032 | 1,000 | $381,400 |
2024-09 | 0 | $0 | 1,100 | $1,296,705 | 1,000 | $381,400 |
2024-08 | 0 | $0 | 26,216 | $30,395,175 | 57,612 | $26,774,228 |
2024-07 | 0 | $0 | 3,103 | $3,328,450 | 1,137 | $423,487 |
2024-06 | 0 | $0 | 29,118 | $29,696,979 | 17,568 | $9,585,550 |
2024-05 | 0 | $0 | 62,158 | $60,932,805 | 206,376 | $82,772,373 |
2024-04 | 0 | $0 | 350 | $337,338 | 0 | $0 |
2024-03 | 0 | $0 | 6,241 | $5,989,385 | 20,000 | $7,993,200 |
2024-02 | 0 | $0 | 23,683 | $22,687,937 | 245,602 | $97,413,523 |
2024-01 | 0 | $0 | 56,295 | $50,854,058 | 65,027 | $28,006,061 |
2023-12 | 0 | $0 | 13,673 | $11,512,537 | 75,569 | $7,612,739 |
2023-11 | 0 | $0 | 7,592 | $6,062,677 | 21,000 | $5,790,000 |
2023-10 | 0 | $0 | 2,038 | $1,708,426 | 2,038 | $778,533 |
2023-09 | 0 | $0 | 250 | $208,637 | 0 | $0 |
2023-08 | 0 | $0 | 32,421 | $27,157,374 | 94,111 | $35,629,776 |
2023-07 | 0 | $0 | 350 | $249,104 | 0 | $0 |
2023-06 | 0 | $0 | 550 | $404,329 | 0 | $0 |
2023-05 | 0 | $0 | 100 | $80,546 | 0 | $0 |
2023-04 | 0 | $0 | 4,270 | $3,433,827 | 4,170 | $2,006,136 |
2023-03 | 0 | $0 | 9,478 | $7,614,217 | 16,140 | $5,032,094 |
2023-02 | 0 | $0 | 25,085 | $19,917,308 | 60,305 | $18,503,172 |
2023-01 | 0 | $0 | 1 | $747 | 1 | $520 |
2022-12 | 0 | $0 | 5,758 | $4,102,718 | 5,758 | $2,466,727 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-11-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 844.61 | 844,610 |
2024-11-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 381.40 | 381,400 |
2024-10-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 1,054.06 | 1,054,060 |
2024-10-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 381.40 | 381,400 |
2024-10-01 | Ryan Arthur F (Director) | Sale | 100 | 1,049.73 | 104,972 |
2024-09-03 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 1,178.73 | 1,178,730 |
2024-09-03 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 381.40 | 381,400 |
2024-09-03 | Ryan Arthur F (Director) | Sale | 100 | 1,179.76 | 117,975 |
2024-08-28 | Fenimore Christopher R. (SVP Finance & CFO) | Sale | 5,680 | 1,205.76 | 6,848,711 |
2024-08-15 | Bassler Bonnie L (Director) | Sale | 756 | 1,170.00 | 884,520 |
2024-08-15 | Bassler Bonnie L (Director) | Option Ex | 756 | 371.40 | 280,778 |
2024-08-15 | Poon Christine A (Director) | Sale | 10,838 | 1,158.39 | 12,554,587 |
2024-08-15 | Poon Christine A (Director) | Option Ex | 10,838 | 413.33 | 4,479,670 |
2024-08-14 | Murphy Andrew J (EVP Research) | Sale | 6,363 | 1,150.69 | 7,321,840 |
2024-08-13 | Murphy Andrew J (EVP Research) | Option Ex | 20,000 | 399.66 | 7,993,200 |
2024-08-07 | Pitofsky Jason (VP Controller) | Sale | 487 | 1,070.00 | 521,090 |
2024-08-07 | Pitofsky Jason (VP Controller) | Option Ex | 487 | 372.46 | 181,388 |
2024-08-02 | Bassler Bonnie L (Director) | Sale | 756 | 1,115.00 | 842,940 |
2024-08-02 | Bassler Bonnie L (Director) | Option Ex | 756 | 371.40 | 280,778 |
2024-08-02 | Stahl Neil (EVP Research and Development) | Option Ex | 23,638 | 555.67 | 13,134,927 |
2024-08-01 | Mccourt Marion (EVP Commercial) | Sale | 1,137 | 1,060.86 | 1,206,197 |
2024-08-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,137 | 372.46 | 423,487 |
2024-08-01 | Ryan Arthur F (Director) | Sale | 100 | 1,090.90 | 108,195 |
2024-07-11 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 1,866 | 1,088.95 | 2,031,980 |
2024-07-01 | Mccourt Marion (EVP Commercial) | Sale | 1,137 | 1,047.11 | 1,190,564 |
2024-07-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,137 | 372.46 | 423,487 |
2024-07-01 | Ryan Arthur F (Director) | Sale | 100 | 1,059.06 | 105,906 |
2024-06-24 | Bassler Bonnie L (Director) | Sale | 756 | 1,062.00 | 802,872 |
2024-06-24 | Bassler Bonnie L (Director) | Option Ex | 756 | 371.40 | 280,778 |
2024-06-24 | Larosa Joseph J (EVP General Counsel and Secret) | Option Ex | 14,450 | 555.67 | 8,029,431 |
2024-06-14 | Brown Michael S (Director) | Sale | 1,535 | 1,040.00 | 1,596,400 |
2024-06-14 | Brown Michael S (Director) | Option Ex | 1,535 | 625.60 | 960,296 |
2024-06-12 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 16,149 | 1,019.06 | 16,456,848 |
2024-06-11 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 9,064 | 1,015.66 | 9,205,942 |
2024-06-06 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 787 | 1,015.02 | 798,820 |
2024-06-05 | Bassler Bonnie L (Director) | Sale | 827 | 1,011.00 | 836,097 |
2024-06-05 | Bassler Bonnie L (Director) | Option Ex | 827 | 380.95 | 315,045 |
2024-05-28 | Brown Michael S | Sale | 1,172 | 974.86 | 1,142,535 |
2024-05-28 | Brown Michael S | Option Ex | 1,172 | 625.60 | 733,203 |
2024-05-21 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 1,865 | 994.90 | 1,855,488 |
2024-05-17 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 22,830 | 979.64 | 22,365,295 |
2024-05-15 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 10,941 | 984.03 | 10,766,239 |
2024-05-14 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Sale | 25,000 | 979.63 | 24,490,750 |
2024-05-13 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Option Ex | 203,204 | 399.66 | 81,212,510 |
2024-05-03 | Sing George L (Director) | Option Ex | 2,000 | 413.33 | 826,660 |
2024-05-01 | Mccourt Marion (EVP Commercial) | Sale | 250 | 889.41 | 222,352 |
2024-05-01 | Ryan Arthur F (Director) | Sale | 100 | 901.47 | 90,146 |
2024-04-01 | Mccourt Marion (EVP Commercial) | Sale | 250 | 964.73 | 241,182 |
2024-04-01 | Ryan Arthur F (Director) | Sale | 100 | 961.56 | 96,156 |
2024-03-14 | Murphy Andrew J (EVP Research) | Sale | 5,783 | 958.88 | 5,545,197 |
2024-03-13 | Murphy Andrew J (EVP Research) | Option Ex | 20,000 | 399.66 | 7,993,200 |
2024-03-01 | Mccourt Marion (EVP Commercial) | Sale | 358 | 967.50 | 346,365 |
2024-03-01 | Ryan Arthur F (Director) | Sale | 100 | 978.23 | 97,823 |
2024-02-26 | Bassler Bonnie L (Director) | Sale | 854 | 979.25 | 836,279 |
2024-02-26 | Bassler Bonnie L (Director) | Option Ex | 854 | 391.92 | 334,699 |
2024-02-26 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 1,000 | 990.00 | 990,000 |
2024-02-26 | Sing George L (Director) | Sale | 1,000 | 992.50 | 992,500 |
2024-02-26 | Sing George L (Director) | Option Ex | 1,000 | 413.33 | 413,330 |
2024-02-23 | Sing George L (Director) | Sale | 500 | 985.00 | 492,500 |
2024-02-23 | Sing George L (Director) | Option Ex | 500 | 413.33 | 206,665 |
2024-02-22 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 1,000 | 967.65 | 967,650 |
2024-02-22 | Sing George L (Director) | Sale | 3,000 | 965.00 | 2,895,000 |
2024-02-22 | Sing George L (Director) | Option Ex | 3,000 | 413.33 | 1,239,990 |
2024-02-15 | Yancopoulos George (Bd. Co-Chair, President & CSO) | Option Ex | 172,723 | 399.66 | 69,030,474 |
2024-02-09 | Fenimore Christopher R. (SVP Finance & CFO) | Sale | 4,919 | 952.92 | 4,687,428 |
2024-02-09 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Option Ex | 35,375 | 376.93 | 13,333,898 |
2024-02-09 | Sing George L (Director) | Sale | 500 | 955.00 | 477,500 |
2024-02-09 | Sing George L (Director) | Option Ex | 500 | 413.33 | 206,665 |
2024-02-08 | Sing George L (Director) | Sale | 500 | 945.00 | 472,500 |
2024-02-08 | Sing George L (Director) | Option Ex | 500 | 413.33 | 206,665 |
2024-02-07 | Larosa Joseph J (EVP General Counsel and Secret) | Sale | 1,000 | 950.00 | 950,000 |
2024-02-07 | Stahl Neil (EVP Research and Development) | Sale | 8,037 | 950.41 | 7,638,469 |
2024-02-05 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 934.71 | 934,710 |
2024-02-02 | Landry Robert E (EVP Finance CFO) | Option Ex | 400 | 378.98 | 151,592 |
2024-02-02 | Stahl Neil (EVP Research and Development) | Option Ex | 30,750 | 399.66 | 12,289,545 |
2024-02-01 | Mccourt Marion (EVP Commercial) | Sale | 273 | 945.61 | 258,151 |
2024-02-01 | Ryan Arthur F (Director) | Sale | 100 | 952.51 | 95,250 |
2024-01-31 | Landry Robert E (EVP Finance CFO) | Option Ex | 400 | 378.98 | 151,592 |
2024-01-30 | Bassler Bonnie L (Director) | Sale | 827 | 959.00 | 793,093 |
2024-01-30 | Bassler Bonnie L (Director) | Option Ex | 827 | 380.95 | 315,045 |
2024-01-24 | Landry Robert E (EVP Finance CFO) | Option Ex | 500 | 378.98 | 189,490 |
2024-01-23 | Fenimore Christopher R. (SVP Controller) | Option Ex | 10,000 | 477.67 | 4,776,650 |
2024-01-23 | Landry Robert E (EVP Finance CFO) | Option Ex | 1,100 | 378.98 | 416,878 |
2024-01-23 | Goldstein Joseph L (Director) | Sale | 2,707 | 950.00 | 2,571,650 |
2024-01-23 | Goldstein Joseph L (Director) | Option Ex | 2,707 | 625.60 | 1,693,499 |
2024-01-17 | Landry Robert E (EVP Finance CFO) | Option Ex | 500 | 378.98 | 189,490 |
2024-01-12 | Landry Robert E (EVP Finance CFO) | Option Ex | 800 | 378.98 | 303,184 |
2024-01-04 | Landry Robert E (EVP Finance CFO) | Option Ex | 500 | 378.98 | 189,490 |
2024-01-03 | Fenimore Christopher R. (SVP Controller) | Option Ex | 10,000 | 477.67 | 4,776,650 |
2024-01-03 | Bassler Bonnie L (Director) | Sale | 826 | 914.00 | 754,964 |
2024-01-03 | Bassler Bonnie L (Director) | Option Ex | 826 | 380.95 | 314,664 |
2024-01-03 | Landry Robert E (EVP Finance CFO) | Option Ex | 1,100 | 378.98 | 416,878 |
2024-01-03 | Larosa Joseph J (EVP General Counsel and Secret) | Option Ex | 34,000 | 399.66 | 13,588,440 |
2024-01-02 | Zoghbi Huda Y (Director) | Sale | 1,117 | 900.00 | 1,005,300 |
2024-01-02 | Zoghbi Huda Y (Director) | Option Ex | 1,117 | 391.92 | 437,774 |
2024-01-02 | Mccourt Marion (EVP Commercial) | Sale | 274 | 873.91 | 239,451 |
2024-01-02 | Landry Robert E (EVP Finance CFO) | Option Ex | 650 | 378.98 | 246,337 |
2024-01-02 | Yancopoulos George (Bd. Co-Chair, President & CSO) | Sale | 33,696 | 900.00 | 30,326,400 |
2023-12-28 | Landry Robert E (EVP Finance CFO) | Option Ex | 850 | 378.98 | 322,133 |
2023-12-27 | Fenimore Christopher R. (SVP Controller) | Sale | 2,448 | 856.71 | 2,097,226 |
2023-12-27 | Landry Robert E (EVP Finance CFO) | Option Ex | 750 | 378.98 | 284,235 |
2023-12-27 | Brown Michael S (Director) | Sale | 2,049 | 898.00 | 1,840,002 |
2023-12-27 | Brown Michael S (Director) | Option Ex | 2,049 | 482.68 | 989,011 |
2023-12-22 | Fenimore Christopher R. (SVP Controller) | Sale | 250 | 846.27 | 211,567 |
2023-12-21 | Fenimore Christopher R. (SVP Controller) | Sale | 1,680 | 843.94 | 1,417,819 |
2023-12-13 | Bassler Bonnie L (Director) | Sale | 610 | 870.00 | 530,700 |
2023-12-13 | Bassler Bonnie L (Director) | Option Ex | 610 | 376.69 | 229,780 |
2023-12-13 | Landry Robert E (EVP Finance CFO) | Option Ex | 1,000 | 378.98 | 378,980 |
2023-12-11 | Yancopoulos George (Bd. Co-Chair, President & CSO) | Option Ex | 25,155 | .00 | 0 |
2023-12-11 | Schleifer Leonard S (Bd. Co-Chair, President & CEO) | Option Ex | 25,155 | .00 | 0 |
2023-12-05 | Murphy Andrew J (EVP Research) | Sale | 6,536 | 816.00 | 5,333,369 |
2023-12-04 | Murphy Andrew J (EVP Research) | Option Ex | 20,000 | 270.43 | 5,408,600 |
2023-12-01 | Ryan Arthur F (Director) | Sale | 100 | 818.55 | 81,854 |
2023-11-14 | Murphy Andrew J (EVP Research) | Sale | 6,492 | 800.35 | 5,195,878 |
2023-11-13 | Murphy Andrew J (EVP Research) | Option Ex | 20,000 | 270.43 | 5,408,600 |
2023-11-07 | Ryan Arthur F (Director) | Sale | 100 | 828.90 | 82,889 |
2023-11-01 | Mccourt Marion (EVP Commercial) | Sale | 1,000 | 783.91 | 783,910 |
2023-11-01 | Mccourt Marion (EVP Commercial) | Option Ex | 1,000 | 381.40 | 381,400 |
2023-10-13 | Zoghbi Huda Y (Director) | Sale | 1,000 | 850.00 | 850,000 |
2023-10-13 | Zoghbi Huda Y (Director) | Option Ex | 1,000 | 391.92 | 391,920 |
2023-10-02 | Mccourt Marion (EVP Commercial) | Sale | 1,038 | 827.00 | 858,426 |
2023-10-02 | Mccourt Marion (EVP Commercial) | Option Ex | 1,038 | 372.46 | 386,613 |
2023-09-01 | Mccourt Marion (EVP Commercial) | Sale | 250 | 834.55 | 208,637 |
2023-08-24 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Sale | 6,197 | 839.93 | 5,205,046 |
2023-08-23 | Fenimore Christopher R. (SVP Controller) | Option Ex | 7,000 | 399.66 | 2,797,620 |
2023-08-23 | Landry Robert E (EVP Finance CFO) | Sale | 223 | 844.00 | 188,212 |
2023-08-23 | Van Plew Daniel P (EVP & General Mgr, Industrial) | Option Ex | 23,125 | 381.40 | 8,819,875 |
2023-08-23 | Poon Christine A (Director) | Sale | 12,280 | 839.53 | 10,309,477 |
2023-08-23 | Poon Christine A (Director) | Option Ex | 12,280 | 273.67 | 3,360,667 |
2023-08-22 | Stahl Neil (EVP Research and Development) | Sale | 11,665 | 841.37 | 9,814,546 |
2023-08-21 | Bassler Bonnie L (Director) | Sale | 853 | 829.00 | 707,137 |
2023-08-21 | Bassler Bonnie L (Director) | Option Ex | 853 | 391.92 | 334,307 |
2023-08-21 | Stahl Neil (EVP Research and Development) | Option Ex | 50,000 | 399.66 | 19,983,000 |
2023-08-10 | Bassler Bonnie L (Director) | Sale | 853 | 789.00 | 673,017 |
2023-08-10 | Bassler Bonnie L (Director) | Option Ex | 853 | 391.92 | 334,307 |
2023-08-01 | Mccourt Marion (EVP Commercial) | Sale | 250 | 744.66 | 186,165 |
2023-08-01 | Ryan Arthur F (Director) | Sale | 100 | 737.75 | 73,774 |
2023-07-03 | Mccourt Marion (EVP Commercial) | Sale | 250 | 710.09 | 177,522 |
2023-07-03 | Ryan Arthur F (Director) | Sale | 100 | 715.83 | 71,582 |
2023-06-01 | Mccourt Marion (EVP Commercial) | Sale | 250 | 736.00 | 184,000 |
2023-06-01 | Ryan Arthur F (Director) | Sale | 200 | 734.44 | 146,886 |
2023-05-01 | Ryan Arthur F (Director) | Sale | 100 | 805.46 | 80,546 |
2023-04-21 | Brown Michael S (Director) | Sale | 3,070 | 798.42 | 2,451,149 |
2023-04-21 | Brown Michael S (Director) | Option Ex | 3,070 | 520.01 | 1,596,430 |
2023-04-03 | Mccourt Marion (EVP Commercial) | Sale | 1,100 | 818.80 | 900,680 |
2023-04-03 | Mccourt Marion (EVP Commercial) | Option Ex | 1,100 | 372.46 | 409,706 |
2023-04-03 | Ryan Arthur F (Director) | Sale | 100 | 819.99 | 81,998 |
2023-03-28 | Landry Robert E (EVP Finance CFO) | Sale | 1,007 | 822.95 | 828,710 |
2023-03-27 | Landry Robert E (EVP Finance CFO) | Sale | 183 | 824.12 | 150,813 |
2023-03-27 | Landry Robert E (EVP Finance CFO) | Option Ex | 3,800 | 380.45 | 1,445,710 |
Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals, Inc. (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.